Search

everythinglearnresearchcommunity

for

Search:↓

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

We need better research to improve alopecia treatment and patient care.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

No cure for female pattern hair loss, but various effective treatments exist.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The hairline-lowering surgery was effective, safe, and left patients satisfied with few complications.

Low iron levels are linked to more hair loss in non-menopausal women.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Herbal preparation effectively promotes hair growth and reduces hair loss.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Carrot extract in gel form may help hair grow better.

The hot-wire hair removal device is no better than shaving.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.